Skip to content

Author

A. Hendifar

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

Treatment-Stratified Immune–Inflammatory Trajectories and Early Response in Patients with Hepatocellular Carcinoma Receiving Systemic Therapy

Background: Systemic therapy outcomes in hepatocellular carcinoma (HCC) remain heterogeneous, and treatment selection is still largely guided by clinical eligibility rather than dynamic biologic response. We evaluated whether accessible standard-of-care immunophenotypic and immune–inflammatory markers, tumor-marker kin...

Ashley Kim, Manaf Alsudaney, Osama Khattab et al. · 0 citations
Open access Aug 2026

l-Glutamine in combination with first-line gemcitabine and nab-paclitaxel in advanced pancreatic ductal adenocarcinoma: an open-label, single-arm, phase 1 GlutaPanc trial

Exogenous l-glutamine has preclinical antitumor activity although formal clinical translation has not been attempted. We conducted a single-arm phase 1 trial to assess the safety and preliminary efficacy of clinical-grade, US Food and Drug Administration-approved l-glutamine therapy with gemcitabine and nab-paclitaxel...

Jun Gong, Hayato Muranaka, So-Yung Choi et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.